About Us

We design and produce FDA cleared advanced medical monitoring equipment for analyzing the performance and functions of a person’s Parasympathetic and Sympathetic (P&S) Nervous Systems, independently and simultaneously. As the sole patent holder of this advanced technology, our equipment is able to detect autonomic dysfunction and autonomic neuropathy underlying illnesses that isn’t as easily detected by existing medical diagnostic technology on the market today….As an example to the value of our technology, our equipment is able to provide physicians more information to improve their assessment and prioritize therapy planning for a broad spectrum of diseases such as heart disease, hypertension, diabetes, depression, anxiety, COPD, orthostatic intolerance, syncope, exercise intolerance, disorders of the brain (e.g. brain injury, including concussion) and nervous system (e.g., MSA, Alzheimer, Parkinson’s), sweating abnormalities, hormone imbalances, and early detection of contracting sepsis.

Our Company

TMCAMS consists of three valuable companies and partnerships that truly differentiate our technology from other providers. Our strategic partnerships are as follows:

TeleMedCare

Provides a professional and robust FDA approved, multi-user vital signs monitor complete with a HIPAA compliant medical provider portal and an easily navigated patient user interface. The understanding and adoption rate of this state-of-the-art technology is growing rapidly since new medical billing codes have facilitated the reimbursement of these specialty services. It applies to chronic care patients that include millions of potential users who have high blood pressure, diabetes, COPD, heart failure, etc. The TeleMedCare solution is suited perfectly for the rapidly expanding market of many millions of assisted living facility residents, executive fitness club members, remotely located seniors, etc.

Ansar

Provides the Patented, FDA cleared, reimbursed, proprietary software technology and algorithms for testing how well a patient’s autonomic nervous system, specifically the Parasympathetic and Sympathetic (“P&S”) branches, are functioning. This painless, non-invasive procedure evaluates the involuntary part of everyone’s neurological make up that manages almost every part of the body’s operation --- a practically endless list that provides a window deep into each patient’s physical well-being. ANSAR testing provides practicing physicians with very detailed and specific data for identifying and analyzing many health conditions, even in the early stages, when treatment can be most effective. It is an advanced approach customized for each patient according to his/her medical history. Cardiovascular disease, diabetes, COPD, Parkinson’s disease, multiple sclerosis, chronic fatigue syndrome, fatigue, anxiety, dizziness, and high blood pressure are just some of the conditions for which ANSAR can provide physicians with more information. It also aids the doctor in prescribing the most effective treatment for each patient -- The diagnosis and treatment for one patient is often different from that of another based on the information from the ANSAR test. Understanding the P&S nervous systems as a key to the medical diagnostic process is becoming increasingly recognized by practicing physicians as the future of preventative medicine and pro-active healthcare.

Our Team

H. W. (Bill) Hankinson – CEO

Has managed multinational business activities for over thirty-five years focusing on value enhancement strategies ---has built management teams, directed change initiatives and created synergistic strategic relationships for expansions and acquisitions. --- has been involved as a senior officer in multi-million dollar international businesses around the globe and has lived in the USA, Saudi-Arabia, Russia, Canada, and Bermuda. He holds a BS degree in Engineering from The Citadel, and an MBA in finance and marketing from the University of South Carolina. He is a Director of Equus Total Return, Inc. a NYSE investment company (EQS).

Steve O’Leary – President & COO

A senior business executive with a rare blend of technical and sales acumen which he has proven by his success in building world-class sales and marketing teams for global companies. He was one of the technical team members in the development of the HIPAA legislation that also provides him with rare knowledge of the security requirements within the medical industry. His customer focused business acumen allows him to design and execute a wide range of revenue generating sales and marketing strategies through direct and indirect channels. Mr. O’Leary also has a proven communication history for successful presentations and for building client relationships with his dynamic, articulate and results oriented focus. (He is a member of the Former Intelligence Officers Association, US Government Security Adviser, Agent # 9374)

Joe Colombo, PhD – CTO & Senior Medical Director

Dr. Colombo’s specialty is in high-end signal processing and the neurosciences. His clinical interest is the Parasympathetic and Sympathetic nervous systems which led him to the founding of ANSAR, Inc. He has published over 100 refereed conference proceedings, journal articles and book chapters, and a medical textbook on the Clinical Autonomic Dysfunction. He is Director of Research for Drexel Medical Schools’ Cardiology Division, a Parasympathetic & Sympathetic Nervous System Consultant for Franklin Cardiovascular Associates, PA, a researcher and a lecturer. Throughout his career he has developed sensory-neuro-prosthetics, neurological measuring devices, and tele-healthcare platforms. For over 27 years he did consulting research for the military and NASA in the areas of life support systems, physiologic measurement devices, signal processing and telemetry systems, data compression systems, and communications and control systems. Medical Societies he is associated with include The American Autonomic Society, International Society for Autonomic Neuroscience, The Acoustical Society of America, The American Heart Association, The Society of Critical Care Medicine, The American Institute of Physics, The Engineering in Medicine and Biology Society, and The Institute of Electrical and Electronic Engineers. Dr. Colombo obtained his B.S. in Electrical Engineering from Rochester Institute of Technology, M.S. in Neuroscience from the University of Rochester, Medical School, and his Ph. D. in Neuroscience (specialty in Bio Medical Engineering) from the University of Rochester, Medical School.

Professor Branko Celler, Branko Celler - Advisor

Prof. Celler has recently been a Principal Scientist at the CSIRO Centre for Computational Informatics and previously the Chief Scientist of the CSIRO ICT (Information and Communication Technology) Centre in Sydney, Australia. He has an international reputation as a leader and innovator in the area of physiological modelling and biological signal processing. Over the last 20 years he has undertaken pioneering work in the application of ICT in the field of health sciences. His research on telehealth for the management of chronic disease in the home, the community, residential care and rural and remote areas is recognized internationally. He was a founding partner of Telemedcare which is recognized for its innovation and excellence in telehealth. Prof. Celler is currently a Fellow of the Academy of Technological Sciences and Engineering (ATSE) and an Emeritus Professor at the University of NSW. He has published more than 220 refereed conference proceedings, journal papers and book chapters. As an acknowledged thought leader in telehealth he has been invited to speak at more than fifty national and international conferences and symposia over the last ten years.

Dr. Nicholas DePace - Advisor

Dr. DePace is board certified in Cardiovascular Disease, Internal Medicine, Echocardiography, Nuclear Medicine and Lipidology. He currently is affiliated with Our Lady of Lourdes Hospital Cardiology Services, Kennedy Hospital-Washington Twp. and Hahnemann Hospital. He also teaches at Hahnemann Hospital where he holds positions as Professor of Medicine and Associate Chief of Cardiology at the Drexel Medical School/Hahnemann. His Franklin Cardiovascular Associates offices are located in Sewell, NJ, Cherry Hill, NJ, and Philadelphia. He is also the owner/operator of several South Jersey Urgent care centers. He currently has an active research lab on Autonomic Dysfunction and is currently in the process of publishing new papers with Joseph Colombo, PHD with whom he co-wrote the book “Clinical Autonomic Dysfunction”. He has lectured and presented research papers here and abroad, including China, Israel, Africa and Europe.

Dr. Howard James Snapper - Advisor

Dr. Snapper is board certified in Interventional Cardiology, Cardiovascular Disease. He currently is affiliated with WellStar Cardiovascular Medicine, WellStar Kennestone Hospital, Marietta, GA. He holds medical licenses in GA, MA, and IL. He continues to lecture and present manuscripts in many disciplines and his continued research in the Autonomic Function.

Branko Celler – EVP and Technical Advisor, Telemedcare Division

Prof. Celler has recently been a Principal Scientist at the CSIRO Centre for Computational Informatics and previously the Chief Scientist of the CSIRO ICT (Information and Communication Technology) Centre in Sydney, Australia. He has an international reputation as a leader and innovator in the area of physiological modelling and biological signal processing. Over the last 20 years he has undertaken pioneering work in the application of ICT in the field of health sciences. His research on telehealth for the management of chronic disease in the home, the community, residential care and rural and remote areas is recognized internationally. He was a founding partner of Telemedcare which is recognized for its innovation and excellence in telehealth. Prof. Celler is currently a Fellow of the Academy of Technological Sciences and Engineering (ATSE) and an Emeritus Professor at the University of NSW. He has published more than 220 refereed conference proceedings, journal papers and book chapters. As an acknowledged thought leader in telehealth he has been invited to speak at more than fifty national and international conferences and symposia over the last ten years.

Phil Viscomi – VP & Partnership Advisor

Growth Advisors in Wilton, Conn. where he provides innovative strategic planning, restructuring, revenue acceleration, and merger and acquisition services. He specializes in high technology business development and in global technology product distribution. Mr. Viscomi’s entrepreneurial background includes roles as board member, President, CEO, P&L manager and leadership team member of six successful technology businesses as well as C-Level advisor/coach to multiple growth stage companies and institutional/private investors. As an executive and entrepreneur, he held leadership positions in major Fortune 50 companies and delivered strong results through double-digit percentage growth of multiple-billion dollar portfolios. Phil also serves as a university guest lecturer, and instructor in business and entrepreneurial topics.

Publication Citings

Original Scientific Articles (Peer-Reviewed)

Bellin DL, DePace NL, Bulgarelli RJ, Peng L, Colombo J. Excessive parasympathetic response to sympathetic challenges: A treatable, hidden, dynamic autonomic imbalance. J Trad Chinese Med Sci. 2015; 2(1): 52-59.

DePace NL, Mears JP; Yayac M, Colombo J. Cardiac autonomic testing and diagnosing heart disease. “A clinical perspective.” Heart International. 2014; 9 (2): 37-44; DOI: 10.5301/heartint.5000218; published online 12/5/2014 12:29:58 PM.

DePace NL, Mears JP; Yayac M, Colombo J. Cardiac autonomic testing and treating heart disease. “A clinical perspective.” Heart International 2014; 9 (2): 45-52; DOI: 10.5301/heartint.5000216; published online 11/19/2014 1:16:08 PM.

Murray GL, Colombo J. Ranolazine improves autonomic balance in heart failure when added to guideline driven therapy. Heart International 2014 ; 9 (2): 59-65; published online 9/23/2014 6:53:43 AM DOI: 10.5301/heartint.5000215.

Murray GL, Colombo J. Ranolazine preserves and improves left ventricular ejection fraction and autonomic measures when added to guideline-driven therapy in chronic heart failure. Heart International 2014 ; 9 (2): 66-73; published online 9/23/2014 6:53:43 AM DOI: 10.5301/heartint.5000219.

Murray GL, Colombo J. Ranolazine therapy reduces non-ST-segment-elevation myocardial infarction and unstable angina in coronary disease patients with angina. Submitted 2013.

Vinik AI, Bloom HL, Colombo J. Differential effects of adrenergic antagonists (carvedilol vs. metoprolol) on parasympathetic and sympathetic activity: A comparison of measures. Heart International. Heart Int. 2014; 9(1): 7-14; DOI: 10.5301/HEART.2014.12495.

Bloom HL, Vinik AI, Colombo J. Differential effects of adrenergic antagonists (carvedilol vs. metoprolol) on parasympathetic and sympathetic activity: A comparison of clinical results. Heart Int. 2014 ; 9 (1): 15-21; DOI: 10.5301/HEART.2014.12496.

Colombo J, Shoemaker WC, Belzberg H, Hatzakis G, Fathizadeh P, Demetriades D. Noninvasive Monitoring of the Autonomic Nervous System and Hemodynamics of Patients With Blunt and Penetrating Trauma. J Trauma. 2008; 65(6): 1364-1373.

Arora RR, Bulgarelli RJ, Ghosh-Dastidar S, Colombo J. Autonomic Mechanisms and Therapeutic Implications of Postural Diabetic Cardiovascular Abnormalities. J Diabetes Science and Technology. 2008; 2(4): 568-71.

Turner IM and Colombo J. Autonomic dysfunction in migraine: A case study. Headache and Pain. 2004, Nov; 15(4): 185-93.

Fathizadeh P, Shoemaker WC, Woo CCJ, and Colombo J: (2004) Autonomic activity in trauma patients based on variability of heart rate and respiratory rate. 2004, Crit Care Med. 32(5), 1300-5. Adiraju RK, Gessman LJ, and Colombo J. (2001) Preliminary applications of the ANS-R1000. MESPE J. 3(1): 33-45.

Books

Colombo J, Arora RR, DePace NL, Vinik AI. Clinical Autonomic Dysfunction: Measurement, Indications, Therapies, and Outcomes. Springer Science + Business Media, New York, NY, 2014.

Book Chapters

Singh R. and Colombo J. Parasympathetic and sympathetic dysfunctions: Signs, symptoms, therapies, and outcomes. In: Neurological Differential Diagnosis; A Case-based Approach. Ettinger AB. and Weisbrot DM. (eds), Cambridge University Press, 2014

Shoemaker WC, Bernad P, and Colombo J. ANS monitoring in closed head injury patients. In: Closed Head Injury. Bernad P., (ed) LexisNexis Group, Newark, NJ, 481-97; 2006.

Colombo J, and Shoemaker WC. Non-invasive autonomic nervous system monitoring in critical care. In: Procedures and Monitoring for the Critically Ill. Shoemaker WC, et al. (eds). W.B. Saunders Co., Philadelphia, PA, 211-24; 2000.

FDA Cleared